PharmaCyte Biotech Inc (PMCB)

[BioNewton]

Pharmacyte will easily get patent extensions, so all the wishful thinking in the world won't stop the inevitable! Now just for the sake of argument, I will indulge those who hope Pharmacyte does not get patent extensions. If they do not get patent extensions (which they will), it would take another company or entity 7-plus years to figure out how to duplicate the treatment. Cell in a Box and the genetically modified cells inside are not a tablet that can easily be reverse engineered.

The entity would first have to figure out which type of cotton is used (there are many cottons and according to Dr. Gunzburg only one type will work) and then make the specific modifications to that one specific type of cotton that allows it to work, then they'd have to create the machines that make the process work, and then they would have to figure out how to genetically modify the cells, and then they would have to figure out the cell growing process to get just the right amount per capsule, and then they'd have to wait for the freezing patent to run out so they could then figure out how this particular product can be frozen so it doesn't have to be used immediately upon production and so they could ship it, and then they'd have to figure out the right placement of the capsules, and the right amount of ifosfamide to use, etc. etc. etc. etc.

Then if they figure all of that out, they'd have to take their newly created product through preclinical studies and clinical trials... And by that time, Pharmacyte would have had FDA approval for a long time and they'd be using the 7 years of marketing exclusivity that the orphan drug status provides.